| Schedule of quarterly financial data |
| |
|
Year Ended July 31, 2016 |
|
| |
|
July 31,
2016 |
|
|
April 30,
2016 |
|
|
January 31, 2016 |
|
|
October 31, 2015 |
|
|
Total |
|
| Revenues |
|
$ |
122 |
|
|
$ |
219 |
|
|
$ |
112 |
|
|
$ |
1,703 |
|
|
$ |
2,156 |
|
| Direct cost of revenues |
|
|
50 |
|
|
|
88 |
|
|
|
13 |
|
|
|
782 |
|
|
|
933 |
|
| Research and development |
|
|
407 |
|
|
|
505 |
|
|
|
374 |
|
|
|
— |
|
|
|
1,286 |
|
| Selling, general and administrative |
|
|
3,538 |
|
|
|
1,528 |
|
|
|
2,346 |
|
|
|
1,612 |
|
|
|
9,024 |
|
| Other income |
|
|
14 |
|
|
|
13 |
|
|
|
400 |
|
|
|
10 |
|
|
|
437 |
|
| Provision for income tax benefits (income taxes) |
|
|
(15 |
) |
|
|
25 |
|
|
|
— |
|
|
|
(6 |
) |
|
|
4 |
|
| Net loss |
|
|
(3,874 |
) |
|
|
(1,864 |
) |
|
|
(2,221 |
) |
|
|
(687 |
) |
|
|
(8,646 |
) |
| Net loss attributable to noncontrolling interests |
|
|
80 |
|
|
|
19 |
|
|
|
195 |
|
|
|
55 |
|
|
|
349 |
|
| Net loss attributable to SPCI |
|
|
(3,794 |
) |
|
|
(1,845 |
) |
|
|
(2,026 |
) |
|
|
(632 |
) |
|
|
(8,297 |
) |
| Loss per share - basic |
|
$ |
(0.32 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.70 |
) |
| Loss per share - diluted |
|
$ |
(0.32 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.70 |
) |
| |
|
Year Ended July 31, 2015 |
|
| |
|
July 31,
2015 |
|
|
April 30,
2015 |
|
|
January 31, 2015 |
|
|
October 31, 2014 |
|
|
Total |
|
| Revenues |
|
$ |
2,769 |
|
|
$ |
2,867 |
|
|
$ |
2,781 |
|
|
$ |
4,823 |
|
|
$ |
13,240 |
|
| Direct cost of revenues |
|
|
1,282 |
|
|
|
1,315 |
|
|
|
1,338 |
|
|
|
2,108 |
|
|
|
6,043 |
|
| Selling, general and administrative |
|
|
2,870 |
|
|
|
1,353 |
|
|
|
1,605 |
|
|
|
1,103 |
|
|
|
6,931 |
|
| Other income |
|
|
322 |
|
|
|
9 |
|
|
|
9 |
|
|
|
32 |
|
|
|
372 |
|
| Provision for (income taxes) income tax benefits |
|
|
(2,660 |
) |
|
|
801 |
|
|
|
(100 |
) |
|
|
(755 |
) |
|
|
(2,714 |
) |
| Net (loss) income |
|
|
(3,721 |
) |
|
|
1,009 |
|
|
|
(253 |
) |
|
|
889 |
|
|
|
(2,076 |
) |
| Net loss (income) attributable to noncontrolling interests |
|
|
529 |
|
|
|
(211 |
) |
|
|
(24 |
) |
|
|
(183 |
) |
|
|
111 |
|
| Net (loss) income attributable to SPCI |
|
|
(3,192 |
) |
|
|
798 |
|
|
|
(277 |
) |
|
|
706 |
|
|
|
(1,965 |
) |
| Income (loss) per share - basic |
|
$ |
(0.28 |
) |
|
$ |
0.07 |
|
|
$ |
(0.02 |
) |
|
$ |
0.06 |
|
|
$ |
(0.17 |
) |
| Income (loss) per share - diluted |
|
$ |
(0.28 |
) |
|
$ |
0.07 |
|
|
$ |
(0.02 |
) |
|
$ |
0.06 |
|
|
$ |
(0.17 |
) |
| |
|
Year Ended July 31, 2014 |
|
| |
|
July 31,
2014 |
|
|
April 30,
2014 |
|
|
January 31, 2014 |
|
|
October 31, 2013 |
|
|
Total |
|
| Revenues |
|
$ |
3,303 |
|
|
$ |
913 |
|
|
$ |
453 |
|
|
$ |
127 |
|
|
$ |
4,796 |
|
| Direct cost of revenues |
|
|
1,751 |
|
|
|
425 |
|
|
|
283 |
|
|
|
28 |
|
|
|
2,487 |
|
| Selling, general and administrative |
|
|
725 |
|
|
|
665 |
|
|
|
1,042 |
|
|
|
569 |
|
|
|
3,001 |
|
| Other income |
|
|
13 |
|
|
|
338 |
|
|
|
4 |
|
|
|
53 |
|
|
|
408 |
|
| Provision for income tax benefits (income taxes) |
|
|
2,393 |
|
|
|
(40 |
) |
|
|
— |
|
|
|
— |
|
|
|
2,353 |
|
| Net income (loss) |
|
|
3,233 |
|
|
|
121 |
|
|
|
(868 |
) |
|
|
(417 |
) |
|
|
2,069 |
|
| Net (income) loss attributable to noncontrolling interests |
|
|
(195 |
) |
|
|
(4 |
) |
|
|
141 |
|
|
|
26 |
|
|
|
(32 |
) |
| Net income (loss) attributable to SPCI |
|
|
3,038 |
|
|
|
117 |
|
|
|
(727 |
) |
|
|
(391 |
) |
|
|
2,037 |
|
| Income (loss) per share - basic |
|
$ |
0.28 |
|
|
$ |
0.01 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.04 |
) |
|
$ |
0.19 |
|
| Income (loss) per share - diluted |
|
$ |
0.27 |
|
|
$ |
0.01 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.04 |
) |
|
$ |
0.18 |
|
|